Seven Fleet Capital Management’s Definium Therapeutics DFTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.14M Sell
108,647
-40,000
-27% -$1.69M 0.81% 22
2026
Q2
$6.99M Buy
148,647
+48,760
+49% +$1.2M 1.15% 21
2026
Q1
$1.89M Buy
+99,887
New +$1.7M 0.59% 39

Other funds holding DFTX

Seven Fleet Capital Management's DFTX Position: Q3 2026 in Review

Seven Fleet Capital Management reduced its Definium Therapeutics (DFTX) stake by 27% in Q3 2026, selling an estimated $1.69M and leaving 108,647 shares worth $4.14M. The position accounts for 0.81% of the portfolio, ranked #22.

Seven Fleet Capital Management first reported a position in DFTX in Q1 2026 and has held it in 3 quarters since. The position peaked at $6.99M in Q2 2026. 354 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.

  • Seven Fleet Capital Management held 108,647 shares of Definium Therapeutics worth $4.14M as of Q3 2026.
  • Seven Fleet Capital Management sold 40,000 Definium Therapeutics shares in Q3 2026, an estimated $1.69M.
  • Definium Therapeutics made up 0.81% of Seven Fleet Capital Management's portfolio in Q3 2026, its #22 holding.
  • Seven Fleet Capital Management first reported a position in Definium Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • Seven Fleet Capital Management's Definium Therapeutics position peaked at $6.99M in Q2 2026.
  • 354 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.

Based on Seven Fleet Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.